ArticleNMR in biomedicine2026
Anomaly Detection for Structural and Functional Connectivity in Glioma Patients.
Article in NMR in biomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical-State Validation Should Precede Patient-Level Use of Glioma Connectivity Anomaly Maps.NMR in biomedicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Brain connectivity, quantified with diffusion MRI (structural connectivity, SC) and resting-state functional MRI (functional connectivity, FC), can offer crucial insights into glioma-brain network interactions. Currently, no standardized approach exists to integrate information from FC and SC and to identify potential tumor-induced abnormalities at the single-patient level. Variational autoencoders (VAEs) have been shown to be promising for learning the distribution of features representing a healthy brain and deviations thereof and can naturally be applicable to multiple modalities. This study explores the potential of VAE to integrate FC and SC and detect multimodal anomalies in brain connectivity in glioma patients. The VAE is trained on concatenated FC-SC healthy data to learn how to reconstruct normative connectivity patterns. After ad hoc transfer learning, the model parameters are applied to the oncological dataset, to obtain the healthy version of the pathological matrices. Given the healthy, pathological, and reconstructed matrices, a statistic is developed with the goal of identifying specific alterations in SC, FC, and their FC + SC integration in glioma patients. SC, FC, and FC + SC abnormalities are compared with each other to explore their interplay and their link with tumor and surrounding brain tissues. Results show that FC is more sensitive to alterations distant from the tumor, while SC is more affected in its vicinity. Then, the alterations identified by FC are generally more in agreement with the alterations identified by FC + SC compared with those highlighted by SC. Moreover, SC abnormalities never overlap with FC + SC out of the tumor, and FC and SC single impairments partially overlap within the tumor core and never overlie in other brain tissues. This information could facilitate patient stratification, prognostic modeling, and personalized treatment planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.